L. Gordon Carl's Insider Trades & SAST Disclosures
L. Gordon Carl's most recent trade in MBX Biosciences Inc. was a trade of 94,100 Common Stock done at an average price of $10.8 . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern L. Gordon Carl.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 94,100 | 747,887 | - | 10.8 | 1,020,044 | Common Stock |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 49,070 | 3,255,000 | - | 10.8 | 531,919 | Common Stock |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.85 per share. | 14 Feb 2025 | 29,540 | 3,205,930 | - | 9.9 | 290,969 | Common Stock |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.90 per share. | 14 Feb 2025 | 17,962 | 3,176,390 | - | 9.9 | 177,824 | Common Stock |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 19,587,284 | 0 | - | - | Series B Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 12,372,634 | 0 | - | - | Series A Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 4,854,368 | 0 | - | - | Series C Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 2,658,428 | 2,658,428 | - | - | Common Stock | ||
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 500,000 | 3,158,428 | - | 16 | 8,000,000 | Common Stock |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | 16 Sep 2024 | 403,787 | 403,787 | - | - | Common Stock | ||
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 250,000 | 653,787 | - | 16 | 4,000,000 | Common Stock |
| MBX Biosciences Inc. | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 220,600 | 899,212 | - | 44.0 | 9,708,606 | Common Stock |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 29,400 | 119,522 | - | 44.0 | 1,293,894 | Common Stock |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 39,433 | 4,843,421 | - | 10 | 394,330 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 6,142 | 756,258 | - | 10 | 61,420 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 5,401 | 1,968,480 | - | 10 | 54,010 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 4,009 | 4,839,412 | - | 10 | 40,090 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 623 | 755,635 | - | 10 | 6,230 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 556 | 1,967,924 | - | 10 | 5,560 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 01 Jul 2024 | 4,676 | 4,676 | - | - | Stock Option (Right to Buy) | ||
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,900 | 11,800 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Compass Therapeutics Inc | Gordon L. Carl | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 821,827 | - | - | Common Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 821,827 | - | - | Common Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 0 | - | - | Series A Preferred Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 0 | - | - | Series A Preferred Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 1,291,442 | - | - | Common Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 1,291,442 | - | - | Common Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 0 | - | - | Series B Preferred Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 0 | - | - | Series B Preferred Stock | ||
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Jan 2024 | 222,222 | 1,513,664 | - | 18 | 3,999,996 | Common Stock |
| ArriVent BioPharma Inc. | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Jan 2024 | 222,222 | 1,513,664 | - | 18 | 3,999,996 | Common Stock |
| Adicet Bio Inc | L. Gordon Carl | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 1,841,100 | 7,526,359 | - | 2.4 | 4,418,640 | Common Stock |
| Adicet Bio Inc | Gordon L. Carl | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 1,041,700 | 1,255,985 | - | 2.4 | 2,500,080 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 242,200 | 990,254 | - | 2.4 | 581,280 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 17 Jul 2023 | 328,482 | 17,063,000 | - | 3.0 | 1,001,870 | Common Stock |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 17 Jul 2023 | 151,450 | 650,600 | - | 3.1 | 461,923 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 442,000 | 5,685,259 | - | 2.1 | 923,780 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 250,000 | 646,657 | - | 2.1 | 522,500 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 125,000 | 1,027,885 | - | 2.1 | 261,250 | Common Stock |
| Adicet Bio Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 58,000 | 748,054 | - | 2.1 | 121,220 | Common Stock |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,900 | 5,900 | - | 0 | Common Stock | |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 04 May 2023 | 490,512 | 1,368,339 | - | 2.8 | 1,383,244 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 04 May 2023 | 490,511 | 1,368,338 | - | 2.8 | 1,383,241 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 04 May 2023 | 312,991 | 4,738,453 | - | 2.7 | 860,725 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 04 May 2023 | 83,459 | 877,827 | - | 2.7 | 229,512 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 04 May 2023 | 83,459 | 877,827 | - | 2.7 | 229,512 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 28 Apr 2023 | 467,068 | 4,204,852 | - | 2.6 | 1,223,718 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 28 Apr 2023 | 228,754 | 3,737,784 | - | 2.6 | 583,323 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 28 Apr 2023 | 220,610 | 4,425,462 | - | 2.7 | 589,029 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 28 Apr 2023 | 124,545 | 735,542 | - | 2.6 | 326,308 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 28 Apr 2023 | 124,544 | 735,542 | - | 2.6 | 326,305 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 28 Apr 2023 | 60,998 | 610,998 | - | 2.6 | 155,545 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 28 Apr 2023 | 60,997 | 610,997 | - | 2.5 | 155,542 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 28 Apr 2023 | 58,826 | 794,368 | - | 2.7 | 157,065 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 28 Apr 2023 | 58,826 | 794,368 | - | 2.7 | 157,065 | Common Stock |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 550,000 | 550,000 | - | - | Common Stock | |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 550,000 | 550,000 | - | - | Common Stock | |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 23 Dec 2022 | 137,931 | 4,882,854 | - | 7.3 | 1,000,000 | Common Stock | |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.21 per share. | 08 Nov 2022 | 402,000 | 15,219,994 | - | 3.2 | 1,290,420 | Common Stock |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.21 per share. | 07 Nov 2022 | 192,000 | 16,734,518 | - | 5.2 | 1,000,320 | Common Stock |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 2,470,200 | 4,744,923 | - | 2.4 | 5,977,884 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 762,400 | 762,400 | - | 2.4 | 1,845,008 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 457,400 | 1,973,881 | - | 2.4 | 1,106,908 | Common Stock | |
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 207,500 | 207,500 | - | - | Pre-Funded Warrant | ||
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 64,050 | 64,050 | - | - | Pre-Funded Warrant | ||
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Aug 2022 | 38,450 | 38,450 | - | - | Pre-Funded Warrant | ||
| Terns Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | 16 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | ||
| Kinnate Biopharma Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Adicet Bio Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 11 May 2022 | 97,094 | 14,787,272 | - | 2.4 | 228,171 | Common Stock |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 11 May 2022 | 64,700 | 14,690,178 | - | 1.8 | 115,813 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges